paclitaxel has been researched along with Cancer of Gallbladder in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, A; Sirohi, B | 1 |
| Chen, W; He, M; Liu, Q; Long, MM; Wang, H; Wang, J; Xu, SW; Yang, LH; Yang, RM; Zhan, M | 1 |
| Gong, W; Ma, M; Qin, Y; Quan, Z; Weng, M; Zhang, M | 1 |
| Berretta, M; Cappellani, A; Cavallaro, A; Di Vita, M; Grosso, G; Lanzafame, S; Piccolo, G; Zanghì, A | 1 |
| Chen, W; He, Y; Peng, J; Song, W; Zhang, S | 1 |
| Eichelmann, K; Fahlke, J; Hribaschek, A; Kuhn, R; Ridwelski, K; Rudolph, S | 1 |
| Block, KI; Ellis, J; Gupta, G; Gyllenhaal, C; Koch, A; Lo, C; Oberbaum, M; Samuels, N; Singer, SR; Tripathy, D | 1 |
| Hoque, A; Jones, DV; Lozano, R; Markowitz, A; Patt, YZ | 1 |
1 review(s) available for paclitaxel and Cancer of Gallbladder
| Article | Year |
|---|---|
Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cholecystectomy, Laparoscopic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogens; Fatal Outcome; Female; Gallbladder Neoplasms; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Neoplasms, Hormone-Dependent; Paclitaxel; Postmenopause; Progesterone; Radiotherapy, Adjuvant | 2011 |
2 trial(s) available for paclitaxel and Cancer of Gallbladder
| Article | Year |
|---|---|
Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas.
Topics: Adult; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cholangiocarcinoma; Deoxycytidine; Docetaxel; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Palliative Care; Survival Analysis; Taxoids | 2002 |
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Biliary Tract Neoplasms; Drug Administration Schedule; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neuromuscular Diseases; Paclitaxel; Remission Induction | 1996 |
5 other study(ies) available for paclitaxel and Cancer of Gallbladder
| Article | Year |
|---|---|
Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer.
Topics: Albumins; Gallbladder Neoplasms; Humans; Paclitaxel | 2020 |
Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Oxaliplatin; Paclitaxel; Xenograft Model Antitumor Assays | 2018 |
Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Humans; Hyaluronic Acid; Mice, Nude; Paclitaxel; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Integrative tumor board: metastatic breast cancer.
Topics: Acupuncture Therapy; Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Complementary Therapies; Drugs, Chinese Herbal; Female; Gallbladder Neoplasms; Homeopathy; Humans; Middle Aged; Paclitaxel | 2006 |